Performance-based managed entry agreements for new medicines in OECD countries and EU member states: How they work and possible improvements going forward
This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey a...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Paris
OECD Publishing
2019
|
| Schriftenreihe: | OECD Health Working Papers
no.115 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines. |
| Beschreibung: | 1 Online-Ressource (101 p.) |
| DOI: | 10.1787/6e5e4c0f-en |
Internformat
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | ZDB-13-SOC-06129697X | ||
| 003 | DE-627-1 | ||
| 005 | 20231204121454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210204s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1787/6e5e4c0f-en |2 doi | |
| 035 | |a (DE-627-1)06129697X | ||
| 035 | |a (DE-599)KEP06129697X | ||
| 035 | |a (FR-PaOEC)6e5e4c0f-en | ||
| 035 | |a (EBP)06129697X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a O38 |2 jelc | ||
| 084 | |a O32 |2 jelc | ||
| 084 | |a I11 |2 jelc | ||
| 084 | |a I13 |2 jelc | ||
| 084 | |a H51 |2 jelc | ||
| 100 | 1 | |a Wenzl, Martin |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Performance-based managed entry agreements for new medicines in OECD countries and EU member states |b How they work and possible improvements going forward |c Martin, Wenzl and Suzannah, Chapman |
| 264 | 1 | |a Paris |b OECD Publishing |c 2019 | |
| 300 | |a 1 Online-Ressource (101 p.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a OECD Health Working Papers |v no.115 | |
| 520 | |a This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines. | ||
| 650 | 4 | |a Social Issues/Migration/Health | |
| 650 | 4 | |a European Union | |
| 700 | 1 | |a Chapman, Suzannah |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/6e5e4c0f-en |3 Volltext |
| 912 | |a ZDB-13-SOC | ||
| 912 | |a ZDB-13-SOC | ||
| 951 | |a BO | ||
| 912 | |a ZDB-13-SOC | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-13-SOC-06129697X |
|---|---|
| _version_ | 1804748651653758976 |
| adam_text | |
| any_adam_object | |
| author | Wenzl, Martin |
| author2 | Chapman, Suzannah |
| author2_role | ctb |
| author2_variant | s c sc |
| author_facet | Wenzl, Martin Chapman, Suzannah |
| author_role | aut |
| author_sort | Wenzl, Martin |
| author_variant | m w mw |
| building | Verbundindex |
| bvnumber | localFWS |
| collection | ZDB-13-SOC |
| ctrlnum | (DE-627-1)06129697X (DE-599)KEP06129697X (FR-PaOEC)6e5e4c0f-en (EBP)06129697X |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1787/6e5e4c0f-en |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01812cam a22004212 4500</leader><controlfield tag="001">ZDB-13-SOC-06129697X</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121454.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210204s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/6e5e4c0f-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)06129697X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP06129697X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)6e5e4c0f-en</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)06129697X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">O38</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">O32</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I11</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I13</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">H51</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wenzl, Martin</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Performance-based managed entry agreements for new medicines in OECD countries and EU member states</subfield><subfield code="b">How they work and possible improvements going forward</subfield><subfield code="c">Martin, Wenzl and Suzannah, Chapman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (101 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Health Working Papers</subfield><subfield code="v">no.115</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">European Union</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chapman, Suzannah</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/6e5e4c0f-en</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-13-SOC-06129697X |
| illustrated | Not Illustrated |
| indexdate | 2024-07-16T15:07:16Z |
| institution | BVB |
| language | English |
| open_access_boolean | |
| owner | DE-863 DE-BY-FWS |
| owner_facet | DE-863 DE-BY-FWS |
| physical | 1 Online-Ressource (101 p.) |
| psigel | ZDB-13-SOC |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | OECD Publishing |
| record_format | marc |
| series2 | OECD Health Working Papers |
| spelling | Wenzl, Martin VerfasserIn aut Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward Martin, Wenzl and Suzannah, Chapman Paris OECD Publishing 2019 1 Online-Ressource (101 p.) Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Health Working Papers no.115 This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines. Social Issues/Migration/Health European Union Chapman, Suzannah MitwirkendeR ctb FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/6e5e4c0f-en Volltext |
| spellingShingle | Wenzl, Martin Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward Social Issues/Migration/Health European Union |
| title | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward |
| title_auth | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward |
| title_exact_search | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward |
| title_full | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward Martin, Wenzl and Suzannah, Chapman |
| title_fullStr | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward Martin, Wenzl and Suzannah, Chapman |
| title_full_unstemmed | Performance-based managed entry agreements for new medicines in OECD countries and EU member states How they work and possible improvements going forward Martin, Wenzl and Suzannah, Chapman |
| title_short | Performance-based managed entry agreements for new medicines in OECD countries and EU member states |
| title_sort | performance based managed entry agreements for new medicines in oecd countries and eu member states how they work and possible improvements going forward |
| title_sub | How they work and possible improvements going forward |
| topic | Social Issues/Migration/Health European Union |
| topic_facet | Social Issues/Migration/Health European Union |
| url | https://doi.org/10.1787/6e5e4c0f-en |
| work_keys_str_mv | AT wenzlmartin performancebasedmanagedentryagreementsfornewmedicinesinoecdcountriesandeumemberstateshowtheyworkandpossibleimprovementsgoingforward AT chapmansuzannah performancebasedmanagedentryagreementsfornewmedicinesinoecdcountriesandeumemberstateshowtheyworkandpossibleimprovementsgoingforward |